Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Feb. 03, 2024	Feb. 04, 2023
Cash flows from operating activities:
Net income	$ 2,338,437	$ 3,056,967
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	39,255	39,279
Undistributed earnings in joint venture - Majestic 21	(22,174)	(22,826)
Return on investment in joint venture-Majestic 21	1,600,889	0
Increase (decrease) in fair market value of equity investments	(50,799)	17,942
Stock-based compensation	33,220	34,989
Decrease (increase) in:
Accounts receivable - trade	595,448	(634,707)
Inventories	1,456,452	138,432
Prepaid expenses and other current assets	70,948	246,908
Interest receivable	(137,759)	(33,723)
(Decrease) increase in:
Accounts payable	(134,981)	(320,294)
Accrued compensation	(13,757)	(77,759)
Accrued expenses and other current liabilities	(35,013)	131,028
Income taxes payable	110,092	931,841
Customer deposits	(3,050,498)	(131,498)
Net cash provided by operating activities	2,799,760	3,376,579
Cash flows from investing activities:
Purchase of property, plant and equipment	(122,444)	(226,549)
Purchase certificates of deposit	(2,882,000)	(1,916,000)
Proceeds from certificates of deposit	1,434,000	0
Collections on interest receivable	77,339	0
Collections on mortgage notes receivable	45	188
Collections on equipment and other notes receivable	0	5,701
Increase in cash surrender value of life insurance	(44,025)	(44,025)
Net cash used in investing activities	(1,537,085)	(2,180,685)
Cash flows from financing activities:
Increase in cash and cash equivalents	1,262,675	1,195,894
Cash and cash equivalents at beginning of period	13,879,358	16,653,449
Cash and cash equivalents at end of period	15,142,033	17,849,343
Supplemental financing activity:
Income taxes paid	$ 675,000	$ 0